The 2009 Annual Scientific Meeting will be held in Toronto
The U.S. Pharmacopeial (USP) is holding its 2009 Annual Scientific Meeting (ASM) in Toronto, Canada, from September 22 to 25. The meeting will deal in important issues relating to the quality of food and drugs, global supply chain management, the challenges of creating follow-on biologics and nanotechnology for drug delivery. With an involvement of more than 200 experts from all over the world, this scientific involvement will focus on such topics as the special challenges posed by biologic products, bioterrorism and advanced techniques for detecting protein, among many others.
“We have a strong international roster of top scientific and regulatory experts in pharmaceuticals, food, biotechnology and measurement,” said Roger L. Williams, M.D., chief executive officer of USP. “Navigating the complexities of global supply chain management, quality of food ingredients and understanding how measurement science can be utilized are key to ensuring the quality and safety of the world’s medicines and food ingredients. I’m looking forward to a rigorous and forward-moving discussion.”
Current economic times are facing a lot of challenges in quality of drugs and foods which need to be addressed urgently, viz. melamine in food products, adulterated heparin, and diethylene glycol in cough syrups and toothpaste –and so on. As such this year’s ASM is especially timely and critical.
A special pre-ASM session will be held on Tuesday on Adulteration and Contamination: Technologies of the Future. This will emphasize on the importance of emerging technologies in protecting the global supply of food and drugs. Speakers include Steve Choquette from the National Institute of Standards and Technology on spectral identification, which allow more precise identification of substandard materials; David Hale from the National Institutes of Health/National Library of Medicine on advanced imaging/high resolution photography; and Anthony Zook from Merck & Company on advanced detection of suspected counterfeit drugs.
Subscribe to the comments for this post